Physician profile
Doris Alan
NPI 1558023754
$894.45
in general payments reported to CMS, 2019-2025
20 companies · $411 in 2025
The $411 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $28.90 · 2022: $178 · 2023: $213 · 2024: $63.26 · 2025: $411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $688.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $687.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $177.33 | 2022-2025 | |
| Mayne Pharma Commercial LLC | $112.75 | 2023-2025 | |
| Astellas Pharma US INC | $104.35 | 2023-2025 | Veozah |
| Shield Therapeutics INC | $77.38 | 2023-2025 | Accrufer |
| Coopersurgical, INC. | $63.29 | 2022-2023 | Paragard T 380a |
| Sage Therapeutics, LLC | $49.50 | 2025 | Zurzuvae |
| Organon LLC | $41.81 | 2022-2023 | Nexplanon |
| Pfizer INC. | $28.90 | 2021 | |
| Smith+Nephew, INC. | $27.84 | 2025 | Stravix |
| Supernus Pharmaceuticals, INC. | $24.55 | 2025 | Qelbree |
| Aspira Women'S Health INC | $24.37 | 2022 | |
| Millicent US INC | $23.70 | 2025 | Intrarosa, Femring |
| Abbvie INC. | $21.17 | 2023 | |
| Evofem Biosciences, INC. | $20.86 | 2025 | Phexxi, Solosec, Phexx |
| Pacira Pharmaceuticals Incorporated | $20.60 | 2023 | Exparel |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $17.74 | 2025 | Slynd |
| Avion Pharmaceuticals | $17.23 | 2022 | |
| Hologic Sales and Service, LLC | $14.26 | 2025 | Thinprep 2000 Processor |
| Verrica Pharmaceuticals INC. | $13.67 | 2024 | Ycanth |
| Tms Neurohealth Centers INC. | $13.15 | 2025 | Tms Neurohealth Centers INC. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Doris Alan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.